Proof‐of‐concept study of anti‐Fel d 1 IgY antibodies in cat food using the MASK‐air® app

Background An innovation to better manage cat‐allergic patients utilises anti‐Fel d 1 IgY antibodies to neutralise Fel d 1 after its production by the cat. However, there is no published study showing its clinical efficacy in humans in a home setting. A longitudinal, open‐label, proof‐of‐concept stu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and translational allergy Jg. 14; H. 5; S. e12353 - n/a
Hauptverfasser:	Bousquet, Jean, Gherasim, Alina, Blay, Frédéric, Mathieu‐Dupas, Eve, Batot, Géraldine, Laune, Daniel, Sousa‐Pinto, Bernardo, Zuberbier, Torsten, Pham‐Thi, Nhân, Hofmann, Bernard, Urban‐Kraemer, Emilie, Nguyen‐Grosjean, Van‐Mai, Lustgarten, Véronique, Defrance, Catherine
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England John Wiley & Sons, Inc 01.05.2024 John Wiley and Sons Inc Wiley
Schlagworte:	Allergens Allergies Antibodies anti‐Fel d 1 antibodies Asthma cat allergy cat food Cats combined symptom‐medication score conjunctivitis Food Hay fever Immunotherapy Original Patients Pollen Questionnaires Rhinitis Variables cat allergy asthma rhinitis combined symptom‐medication score conjunctivitis cat food anti‐Fel d 1 antibodies
ISSN:	2045-7022, 2045-7022
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!